A Phase 1 Study to Evaluate the Safety and Target Engagement of EXL01 in the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Mild to Moderate Crohn's Disease

2022-502241-99-00 Protocol EXL01-CD-001 Human pharmacology (Phase I) - First administration to humans Ended

Start 20 Mar 2023 · End 28 May 2024 · Status Ended · 2 EU/EEA countries · 10 sites · Protocol EXL01-CD-001

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ended
Participants planned 50
Countries 2
Sites 10

Crohn's Disease

Key facts

Sponsor
Exeliom Biosciences
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Digestive System Diseases [C06]
Trial duration
20 Mar 2023 → 28 May 2024
Decision date (initial)
2023-08-07
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

External identifiers

EU CT number
2022-502241-99-00
EudraCT number
2021-003432-81
ClinicalTrials.gov
NCT05542355

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Crohn's Disease

VersionLevelCodeTermSystem organ class
20.0 PT 10011401 Crohn's disease 100000004856

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Exeliom Biosciences

Sponsor organisation
Exeliom Biosciences
Address
67 Rue Des Godrans
City
Dijon
Postcode
21000
Country
France

Scientific contact point

Organisation
Exeliom Biosciences
Contact name
Clinical Trial Information Desk

Public contact point

Organisation
Exeliom Biosciences
Contact name
Clinical Trial Information Desk

Locations

2 EU/EEA countries · 10 investigational sites

By country

CountryMS statusPlanned subjectsSites
Belgium Ended 6 2
Poland Ended 44 8
Rest of world 0

Investigational sites

Belgium

2 sites · Ended
Imelda
Imeldaziekenhuis Bonheiden - Department of Gastroenterology, Imeldalaan 9, 2820, Bonheiden
CHU de Liege
Gastro-Endoscopie-Digestive, Domaine Universitaire du Sart-Tilman B35, 4000, Liege

Poland

8 sites · Ended
Planetmed Sp. z o.o.
Gastroenterology, Ul. Lubinowa 12/8, 52-210, Wroclaw
Oddział Gastroenterologiczny SPZOZ w Łęczne
Gastroenterologii, ul. Krasnystawska 52, 21-010, Lcczna
WIP Warsaw IBD Point Profesor Kierkus
Gastroenterology, ul. Bobrowiecka 9b, 00-728, Warszawa
Endoskopia Sp. z o.o.
Gastroenterology, Ul. Boleslawa Chrobrego 6/8, 81-756, Sopot
Niepubliczny Zakład Opieki Zdrowotnej - Vivamed
Vivamed-Gastroenterology, ul. Zamiejska 17, 03-580, Warszawa
Centrum Medyczne "Medyk" Sp. zo.o. Sp.K
Gastroenterology, Al. Tadeusza Rejtana 53, 35-326, Rzeszow
Centrum Zdrowia MDM
Department of Hepatology - Gastroenterology, ul. Inflancka 4 A, 00-189, Warszawa
MEDRISE Sp. z o.o
Gastroenterology, ul. Onyksowa 10, ONYKSOWA Filia nr 2, Lublin

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Belgium 2023-08-21 2023-08-21 2024-05-28
Poland 2023-03-20 2023-03-20 2024-05-28

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2023-06-15 Belgium Acceptable
2023-07-20
2023-08-07
2 SUBSTANTIAL MODIFICATION SM-1 2023-09-22 Belgium Acceptable
2023-11-17
2023-11-20